Masimo Corporation

Masimo Corporation

MASI
Masimo CorporationUS flagNASDAQ Global Select
158.35
USD
-1.10
(-0.69%)
-5.46EPS
-29.00P/E
8.59BMarket Cap
Aug 04Next Earn
Capital Structure

in mil. unless spec.
Working Capital

in mil. unless spec.
Growth Rates

in mil. unless spec.
Quarterly Revenue

in mil. unless spec.
Quarterly Earnings Per Share

in mil. unless spec.
Quarterly Dividends Per Share

in mil. unless spec.

Company Description

CEO
Catherine M. Szyman
Full Time Employees
3,600
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Address
52 Discovery Irvine CA United States of America 92618
IPO Date
Aug 8, 2007
Website
masimo.com
Similar Companies
Business
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.

Company News

  • Masimo Joins Innovators' Network at American Heart Association Center for Health Technology & Innovation

  • MASIMO CORPORATION INVESTIGATION ALERT: Johnson Fistel, PLLP Investigates Potential Breach of Fiduciary Duties by Masimo Officers and Directors

  • MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties

  • New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia

  • MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties

  • Masimo to Present in the Jefferies Global Healthcare Conference

  • MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties

  • Is Masimo (MASI) a Solid Growth Stock? 3 Reasons to Think "Yes"

  • MASI Stock Slips Despite Q1 Earnings and Revenue Beat, Margins Expand

  • Masimo to Present in the BofA Securities 2025 Health Care Conference

  • Masimo Corporation (MASI) Q1 2025 Earnings Call Transcript

  • Masimo (MASI) Q1 Earnings and Revenues Surpass Estimates

  • Samsung Electronics says unit Harman acquires Masimo's audio business for $350 mln

  • Masimo Reports First Quarter 2025 Results

  • Masimo to Sell Consumer Audio Business to HARMAN International

  • Masimo to Sell Audio Business to Harman After Investor Outrage

  • Watch These 3 MedTech Stocks for Q1 Earnings: Beat or Miss?

  • Baron Health Care Fund Q1 2025 Top Net Purchases And Sales

  • Why Masimo (MASI) Could Beat Earnings Estimates Again

  • Why You Shouldn't Bet Against Masimo (MASI) Stock